With regard to the use of new biotechnologies for the detection of human and animal diseases, some international biotechnology companies have succeeded in producing a series of rapid personal tests based primarily on the use of monoclonal antibodies.
These include a cancer diagnosis group, another respiratory and gastrointestinal test group, a sensitivity group, a group to test organ transplant potential, and a pregnancy detection group.
These include a cancer diagnosis group, another respiratory and gastrointestinal test group, a sensitivity group, a group to test organ transplant potential, and a pregnancy detection group.
